| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01485367 | Senile Purpura | Drug: adapalene gel 0.3% | Multispecialty Aesthetic Clinical Research Organization|Galderma Laboratories, L.P. | Phase 2 | 2011-12-01 | 2012-04-19 |
| NCT01213199 | Acne Scars | Drug: Adapalene | Galderma | Phase 2 | 2011-03-01 | 2015-03-09 |
| NCT01406080 | Photoaging|Photodamage | Drug: Adapalene|Drug: Tretinoin | Galderma Brasil Ltda. | Phase 3 | 2013-01-01 | 2013-01-22 |
| NCT00598832 | Acne Vulgaris | Drug: Adapalene lotion 0.1%|Drug: Adapalene Lotion Vehicle | Galderma | Phase 3 | 2007-11-01 | 2011-03-21 |
| NCT02173054 | Acne | Other: Adapalene gel with Eucerin|Other: Adapalene gel|Other: Adapalene gel with placebo moisturizer | Mahidol University | Phase 3 | 2014-07-01 | 2016-11-28 |
| NCT00599521 | Acne Vulgaris | Drug: Adapalene lotion 0.1%|Drug: Adapalene Lotion Vehicle | Galderma | Phase 3 | 2007-11-01 | 2011-03-21 |
| NCT02411942 | Acne Vulgaris | Drug: Adapalene Gel 0.3%|Drug: Differin|Drug: Placebo | Taro Pharmaceuticals USA | Phase 1 | 2014-08-01 | 2015-04-07 |
| NCT01046565 | Skin Manifestations | Drug: adapalene cream 0.1%|Drug: adapalene lotion 0.1% | Galderma Laboratories, L.P. | Phase 1 | 2010-01-01 | 2011-11-15 |
| NCT01046396 | Skin Manifestations | Drug: adapalene cream 0.1% and adapalene lotion 0.1%|Drug: adapalene lotion 0.1% | Galderma Laboratories, L.P. | Phase 1 | 2010-01-01 | 2012-09-21 |
| NCT01182636 | Acne Vulgaris | Drug: Adapalene|Drug: Differin|Drug: Placebo | Teva Pharmaceuticals USA | Phase 1 | 2007-07-01 | 2010-11-22 |
| NCT00647556 | Photoaging | Drug: adapalene gel, 0.3%|Drug: tretinoin 0.05% emollient cream | Galderma Laboratories, L.P. | Phase 3 | 2008-04-01 | 2012-09-21 |
| NCT00687908 | Acne | Drug: Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel|Drug: Vehicle Gel | Galderma | Phase 3 | 2008-11-01 | 2010-09-30 |
| NCT01149330 | Acne Vulgaris | Drug: Adapalene-BPO Gel | Galderma Brasil Ltda. | Phase 4 | 2010-07-01 | 2012-03-09 |
| NCT02932267 | Acne Vulgaris | Drug: Adapalene 0.3% / BPO 2.5% gel | Galderma | Phase 3 | 2016-12-01 | 2016-10-25 |
| NCT00688064 | Severe Acne Vulgaris | Drug: Adapalene BPO Gel associated with Doxycyline Hyclate|Drug: Vehicle Gel associated with Doxycycline Hyclate | Galderma | Phase 3 | 2008-08-01 | 2010-03-31 |
| NCT01095640 | Acne Vulgaris | Drug: adapalene 0.3% topical gel | Actavis Mid-Atlantic LLC|Actavis Inc. | | 2009-03-01 | 2010-03-29 |
| NCT01209949 | Acne Vulgaris | Drug: Adapalene 0.1% and Benzoyl Peroxide 2.5% gel | Galderma Laboratories, L.P. | Phase 4 | 2010-10-01 | 2012-01-18 |
| NCT02721173 | Acne Vulgaris | Drug: Tazarotene 0.1% gel plus clindamycin 1% gel|Drug: Adapalene 0.1% gel plus clindamycin 1% gel | All India Institute of Medical Sciences, Bhubaneswar | Phase 4 | 2016-04-01 | 2017-01-17 |
| NCT01742637 | Acne Vulgaris | Drug: Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|Drug: Epiduo Gel|Drug: Placebo | Taro Pharmaceuticals USA | Phase 1 | 2012-10-01 | 2014-03-08 |
| NCT00660985 | Acne Vulgaris | Drug: Adapalene|Drug: Adapalene | Galderma | Phase 4 | 2008-05-01 | 2011-01-19 |
| NCT01951417 | Acne | Drug: Adapalene/BPO Gel|Other: Moisturizer SPF 30|Other: Foam Wash | Galderma Laboratories, L.P. | Phase 4 | 2013-10-01 | 2016-02-17 |
| NCT02735421 | Acne Vulgaris|Atrophic Acne Scars | Drug: Adapalene 0.3% / BPO 2.5% gel|Drug: Vehicle gel | Galderma | Phase 4 | 2016-05-01 | 2017-01-02 |
| NCT00807014 | Acne Vulgaris | Drug: Duac Gel|Drug: Differin gel | Stiefel, a GSK Company|GlaxoSmithKline | Phase 4 | 2006-11-01 | 2012-03-15 |
